A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT00962832. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rontalizumab (rhuMAb IFNalpha) in Patients With Moderately to Severely Active Systemic Lupus Erythematosus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase II, randomized, double-blind, placebo-controlled multicenter study to evaluate the efficacy and safety of rontalizumab compared with placebo in patients with moderately to severely active systemic lupus erythematosus (SLE).
Study identification
- NCT ID
- NCT00962832
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 238 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2009 (Type not available)
- Primary completion
- Jan 2012 (Actual)
- Completion
- Aug 2013 (Actual)
- Last update posted
- Aug 12, 2016
2009 – 2013
United States locations
- U.S. sites
- 49
- U.S. states
- 21
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anniston | Alabama | 36207 | — |
| Not listed | Birmingham | Alabama | 35294 | — |
| Not listed | Tucson | Arizona | 85724 | — |
| Not listed | La Jolla | California | 92037 | — |
| Not listed | Long Beach | California | 90806 | — |
| Not listed | Los Angeles | California | 90048 | — |
| Not listed | Palo Alto | California | 94304 | — |
| Not listed | San Leandro | California | 94578 | — |
| Not listed | Upland | California | 91786 | — |
| Not listed | Aventura | Florida | 33180 | — |
| Not listed | Clearwater | Florida | 33765 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Atlanta | Georgia | 30303 | — |
| Not listed | Coeur d'Alene | Idaho | 83814 | — |
| Not listed | Chicago | Illinois | 60612 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Kansas City | Kansas | 66160 | — |
| Not listed | Baton Rouge | Louisiana | 70809 | — |
| Not listed | Cumberland | Maryland | 21502 | — |
| Not listed | Hagerstown | Maryland | 21740 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Ann Arbor | Michigan | 48109 | — |
| Not listed | Brooklyn | New York | 11203 | — |
| Not listed | Great Neck | New York | 11020 | — |
| Not listed | Manhasset | New York | 11030 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | New York | New York | 10021 | — |
| Not listed | Rochester | New York | 14618 | — |
| Not listed | Roslyn | New York | 11576 | — |
| Not listed | Chapel Hill | North Carolina | 27599 | — |
| Not listed | Charlotte | North Carolina | 28210 | — |
| Not listed | Greenville | North Carolina | 27834 | — |
| Not listed | Winston-Salem | North Carolina | 27157 | — |
| Not listed | Cleveland | Ohio | 44109 | — |
| Not listed | Oklahoma City | Oklahoma | 73104 | — |
| Not listed | Tulsa | Oklahoma | 74104 | — |
| Not listed | Bethlehem | Pennsylvania | 18015 | — |
| Not listed | Philadelphia | Pennsylvania | 19141 | — |
| Not listed | Pittsburgh | Pennsylvania | 15213 | — |
| Not listed | Charleston | South Carolina | 29406 | — |
| Not listed | Charleston | South Carolina | 29425 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Dallas | Texas | 75390 | — |
| Not listed | Houston | Texas | 77004 | — |
| Not listed | Houston | Texas | 77034 | — |
| Not listed | Houston | Texas | 77074 | — |
| Not listed | Sugar Land | Texas | 77479 | — |
| Not listed | Arlington | Virginia | 22205 | — |
| Not listed | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00962832, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 12, 2016 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00962832 live on ClinicalTrials.gov.